United States · FDA National Drug Code directory
Lidocaine Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0409-4282_05d1a200-9d75-4e48-b14a-5069d4ab816f
- Product NDC
- 0409-4282
- Form
- INJECTION, SOLUTION
- Composition / generic term
- LIDOCAINE HYDROCHLORIDE
- Labeler
- Hospira, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20050914
- Source listing expiry
- 20271231
Source-listed ingredients
- LIDOCAINE HYDROCHLORIDE — 20 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 5 CELLO PACK in 1 PACKAGE (0409-4282-01) / 5 AMPULE in 1 CELLO PACK (0409-4282-25) / 2 mL in 1 AMPULE (0409-4282-11) · 0409-4282-01
- 25 AMPULE in 1 CARTON (0409-4282-02) / 10 mL in 1 AMPULE (0409-4282-12) · 0409-4282-02
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →